CD9 and hepatocellular carcinoma: The membrane protein CD9 from mouse hepatocellular sEVs can be fused with the therapeutic miRNA, allowing the miRNA to be encapsulated in sEVs and delivered to hepatocellular carcinoma cells for treatment (20).